| SpectraBase Spectrum ID |
5ZLPPr4pSeO |
| Name |
5-APDI N,N-bis(3-fluorobenzyl) |
| Classification |
Amphetamine designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
391.211156199 u |
| Formula |
C26H27F2N |
| InChI |
InChI=1S/C26H27F2N/c1-19(13-20-11-12-23-7-4-8-24(23)14-20)29(17-21-5-2-9-25(27)15-21)18-22-6-3-10-26(28)16-22/h2-3,5-6,9-12,14-16,19H,4,7-8,13,17-18H2,1H3 |
| InChIKey |
IGQLUZDHFUVNRC-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
391.506 g/mol |
| Nominal Mass |
391 u |
| Quality |
971 |
| Retention Index |
2769 |
| SMILES |
C(N(CC=1C=C(C=CC1)F)CC=1C=C(C=CC1)F)(CC=1C=C2C(=CC1)CCC2)C |
| SPLASH |
splash10-0bt9-1960000000-04dbaa7889752a5892c6 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N,N-Bis(3-fluorobenzyl)-1-(indan-5-yl)propan-2-amine
1-(2,3-Dihydro-1H-inden-5-yl)-N,N-bis(3-fluorobenzyl)propan-2-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_021090 |
